| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.19 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.052 | 0.3 |